Cellebrite DI Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	189.52	87.65	145.97	133.85	81.68
Short-Term Investments	113.41	95.98	35.59	108.93	123.71
Cash & Cash Equivalents	302.92	183.62	181.57	242.77	205.39
Cash Growth	64.97%	1.13%	-25.21%	18.20%	-
Receivables	77.27	78.76	67.51	66.32	44.24
Inventory	9.94	10.18	6.51	4.75	3.96
Other Current Assets	31.95	23.37	17.63	10.42	8.3
Total Current Assets	422.08	295.93	273.21	324.27	261.88
Property, Plant & Equipment	30.16	32.91	16.76	16.11	14.82
Long-Term Investments	28.86	22.13	0	0	0
Goodwill and Intangibles	37.42	38.08	38.06	16.07	0
Other Long-Term Assets	14.37	14.24	11.76	7.94	3.53
Total Long-Term Assets	110.8	107.36	66.57	40.12	18.36
Total Assets	532.89	403.29	339.78	364.39	280.24
Accounts Payable	53.13	50.07	63.59	53.84	29.7
Deferred Revenue	242.82	194.88	159.41	138.98	88.39
Current Debt	4.97	5	0	0	0
Other Current Liabilities	-47.1	-42.17	-36.43	-33.44	-18.93
Total Current Liabilities	253.82	207.78	186.57	159.38	99.16
Long-Term Debt	9.16	10.35	0	0	0
Other Long-Term Liabilities	235.69	111.3	226.56	40	21.05
Total Long-Term Liabilities	244.85	121.65	226.56	40	21.05
Total Liabilities	498.67	329.43	413.13	199.38	120.21
Total Debt	14.13	15.36	0	0	0
Debt Growth	-7.99%	-	-	-	-
Retained Earnings	118.14	199.24	78.44	28.34	32.56
Comprehensive Income	1.05	0.33	1.37	1.32	0.8
Shareholders' Equity	34.21	73.87	-73.35	63.8	58.83
Net Cash / Debt	288.79	168.27	181.57	242.77	205.39
Net Cash / Debt Growth	71.63%	-7.32%	-25.21%	18.20%	-
Net Cash Per Share	1.52	0.86	1.12	1.96	1.69
Working Capital	168.26	88.15	86.64	164.89	162.72
Book Value Per Share	0.18	0.40	-0.51	0.52	0.48

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).